Pituitary Adenomas: Prolactinomas and Hormone Imbalances Explained

When your body’s natural hormone balance gets thrown off, it’s not always obvious why. You might feel tired, lose your period, have trouble getting pregnant, or notice milk coming from your breasts even if you’re not nursing. For many people, the real culprit is a tiny, non-cancerous tumor in the pituitary gland called a prolactinoma. It’s the most common type of pituitary adenoma, making up nearly half of all cases. And while it sounds scary, it’s one of the most treatable hormone disorders out there-if you know what to look for.

What Exactly Is a Prolactinoma?

The pituitary gland sits at the base of your brain, no bigger than a pea. But it controls a lot: thyroid function, stress response, growth, and reproduction. A prolactinoma is a benign tumor that makes too much prolactin, the hormone that triggers milk production. In women, high prolactin levels can stop ovulation and periods. In men, it can lower testosterone, reduce sex drive, and cause erectile dysfunction. About 95% of women with prolactinomas have these symptoms. In men, it’s closer to 80%.

Not all pituitary tumors make hormones. Some just sit there and press on nearby structures. But prolactinomas are different-they’re active. And they’re common. Studies show about 1 in 10 people have some kind of pituitary growth, but only a small fraction ever cause symptoms. The ones that do? Most are under 1 centimeter. Those are called microadenomas. Larger ones, over 1 cm, are macroadenomas. When a prolactinoma gets big enough, it can squash the optic nerve and cause vision problems-especially loss of peripheral vision. That’s why an MRI is critical if your prolactin levels are high.

How Do You Know You Have One?

It starts with a blood test. If your prolactin level is over 150 ng/mL, there’s a 95% chance it’s a prolactinoma. Levels above 200 ng/mL almost always mean a larger tumor. But don’t jump to conclusions. Stress, pregnancy, certain medications (like antidepressants or stomach acid blockers), and even nipple stimulation can temporarily raise prolactin. That’s why doctors don’t diagnose based on one test. They’ll repeat it, check thyroid function (because low thyroid can also raise prolactin), and order a high-resolution MRI of the pituitary.

For tumors bigger than 1 cm, they’ll also check your vision. A simple field-of-view test can catch early damage. If your peripheral vision is fading, it’s a red flag that the tumor is pressing on the optic chiasm. This isn’t rare. About 20% of all pituitary adenomas are macroadenomas, and many of those are prolactinomas.

Medical Treatment: The First Line of Defense

Here’s the good news: for most people, medication alone can shrink the tumor and bring prolactin back to normal. The go-to drugs are dopamine agonists-medications that trick the brain into thinking there’s enough prolactin already. The two main ones are cabergoline and bromocriptine.

Cabergoline is the clear winner. It’s taken just twice a week, works better, and has fewer side effects. Studies show it normalizes prolactin in 80-90% of small tumors and 70% of large ones within three months. It also shrinks the tumor in 85% of cases. Most patients start at 0.25 mg twice a week. If prolactin doesn’t drop, the dose goes up slowly-usually by 0.25 mg every two weeks. The goal is the lowest dose that keeps prolactin normal.

Bromocriptine works too, but it’s harder to tolerate. People often get nauseous, dizzy, or lightheaded, especially at first. About 32% of users quit bromocriptine because of side effects. Only 18% stop cabergoline. That’s why most doctors start with cabergoline unless there’s a reason not to.

One thing to watch: long-term use of cabergoline (over 2.5 mg per week for more than three years) can, in rare cases, affect heart valves. That’s why the European Society of Endocrinology recommends an echocardiogram after a year and then every two years if you’re on high doses. The FDA has a black box warning for this, but the risk is low for most people on standard doses.

Surgery: When Medication Isn’t Enough

Surgery isn’t the first choice-but it’s a powerful option when needed. The standard procedure is transsphenoidal surgery: a tiny incision through the nose or upper gum to reach the pituitary. No skull is opened. No visible scar.

For small tumors, success rates are high-85-90% of patients get cured. The tumor is removed completely, prolactin drops fast, and many people can stop medication altogether. But for larger tumors that have spread into the cavernous sinus (a complex area near the brain), the cure rate drops to 30-50%. Even if the tumor is mostly removed, prolactin might stay elevated, meaning you still need medicine.

Surgery carries risks: a leak of spinal fluid (2-5%), temporary diabetes insipidus (5-10%), or, rarely, pituitary apoplexy (sudden bleeding into the tumor). Most patients are out of the hospital in 3-5 days. Many report feeling better within weeks. One case from Mayo Clinic followed a 34-year-old woman with a 2.4 cm tumor and prolactin levels at 5,200 ng/mL. After six months on cabergoline, her levels dropped to 18 ng/mL. Her tumor shrank by 70%. She didn’t need surgery.

Radiation: The Slow Option

Radiation is rarely used today as a first step. It takes years to work. Most patients still have symptoms after one year. It’s usually reserved for tumors that won’t shrink with meds or surgery, or for people who can’t tolerate either.

There are a few types. Fractionated radiation delivers small doses over 5-6 weeks. Gamma Knife uses a single high-dose beam focused precisely on the tumor. Proton therapy is newer and even more targeted. Gamma Knife has a 95% control rate at five years and much less risk to the optic nerve than older radiation methods.

The downside? It can take 2-5 years to lower prolactin. And about 30-50% of patients end up with low hormone levels in the pituitary (hypopituitarism) within 10 years. That means lifelong replacement therapy for thyroid, cortisol, or sex hormones. That’s why doctors avoid it unless absolutely necessary.

What Happens After Treatment?

Even if your prolactin normalizes and the tumor shrinks, you’re not done. You need monitoring. For the first year, prolactin is checked every three months. If it stays stable, once a year is enough. MRI scans aren’t needed every year unless symptoms come back.

One big mistake patients make: stopping medication too soon. Prolactin rebounds within 72 hours of missing a dose. Some people feel fine and quit. Then their periods stop again. Or their sex drive vanishes. Or the tumor grows back. That’s why adherence matters more than most realize.

Women who want to get pregnant can often stop cabergoline once pregnant-since prolactin naturally rises during pregnancy. But they need close monitoring. Men should check testosterone levels after treatment. If they’re low, replacement therapy might be needed.

What’s Next in Treatment?

The field is moving fast. In 2023, the FDA approved paltusotine for acromegaly-a related pituitary disorder-and trials are now testing it for prolactinomas. Researchers are also looking at CRISPR gene editing to fix mutations linked to tumor growth, like MEN1. AI is being used to plan surgeries with 3D models of individual pituitary anatomy.

But the biggest shift? Personalized medicine. Scientists now know that tumors with certain gene mutations (like GNAS or USP8) behave differently. In the next five years, we’ll likely see treatment choices based on a tumor’s genetic profile-not just its size. One expert predicts this could raise cure rates from 70% to 90%.

Still, 30% of large prolactinomas don’t respond well to current treatments. That’s why research continues. For now, though, the message is clear: if you have unexplained hormone symptoms, get tested. Prolactinoma isn’t just a diagnosis-it’s a solvable puzzle.